Table 1.
FBXO22 staining and clinicopathological characteristics of 277 renal cancer patients.
|
Variables |
FBXO22 staining | |||
|---|---|---|---|---|
| Low (%) | High (%) | Total | P * | |
|
All cases
Age |
148 (53.4) | 129 (46. 6) | 277 | |
| ≤56 years | 65 (50.8) | 63 (49.2) | 128 | 0.413 |
| >56 years | 83 (55.7) | 66 (44.3) | 149 | |
| Gender | ||||
| Male | 98 (54.1) | 83 (45.9) | 181 | 0.744 |
| Female | 50 (52.1) | 46 (47.9) | 96 | |
| Tumor size | ||||
| ≤7 cm | 108 (50.2) | 107 (49.8) | 215 | 0.047 |
| >7 cm | 40 (64.5) | 22 (35.5) | 62 | |
| pT status | ||||
| pT1 | 89 (48.9) | 93 (51.1) | 182 | 0.036 |
| pT2-T4 | 59 (62.1) | 36 (37.9) | 95 | |
| pN status | ||||
| pN0 | 131 (52.0) | 121 (48.0) | 252 | 0.023 |
| pN1-N3 | 15 (78.9) | 4 (21.1) | 19 | |
| TNM stage | ||||
| I | 77 (47.5) | 85 (52.5) | 162 | 0.020 |
| II-IV | 53 (63.1) | 31 (36.9) | 84 | |
* Two sided Fisher's exact tests.
Some cases were not available for the information.